Ryutaro Tominaga

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Venues

Leukemia & lymphoma

Pathology international

This page only lists publications with an associated author ORCID identifier.

Publications

Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Kazuki Hyodo, Shin-Ichiro Kawaguchi, Yumiko Toda, Kento Umino, Daisuke Minakata, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma 65 (9) (2024)
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Kazuki Hyodo, Shin-Ichiro Kawaguchi, Yumiko Toda, Kento Umino, Daisuke Minakata, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma (2024)
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Kazuki Hyodo, Shin-Ichiro Kawaguchi, Yumiko Toda, Kento Umino, Daisuke Minakata, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma 65 (9) (2024)
Ryutaro Tominaga, Kazuki Yoshimura, Masakatsu Kawamura, Shinichi Kako, Yoshinobu Kanda, Haruka Morikawa, Shiori Ando, Naota Okabe, Masahiro Hiruta, Akira Tanaka, Hisashi Oshiro
Secondary Budd-Chiari syndrome caused by adult T-cell leukemia/lymphoma. Pathology international (2023)

Ryutaro Tominaga.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ryutaro Tominaga